Cent Eur J Public Health 2017, 25(1):67-71
Care for Haemoglobinopathy Patients in Slovakia
- 1 Department of Haematology, Hospital St. Michael, Bratislava, Slovakia
- 2 Laboratory of Haematology, Synlab Slovakia, Bratislava, Slovakia
- 3 Laboratory of Molecular Genetic, Faculty Hospital, Nitra, Slovakia
- 4 Department of Haematology, Paediatric Faculty Hospital, Bratislava, Slovakia
- 5 Department of Haematology, L. Pasteur Faculty Hospital, Košice, Slovakia
Background: The paper presents the results od 22-year study of screening and follow-up of haemoglobinopathies in Slovakia, an overview of genetic mutations, the coincidence with hereditary haemochromatosis mutations, and the procedure in genetic councelling.
Methods: Between 1993-2015, in three centres in Bratislava and in one centre in Kosice, carriers of beta-thalassaemic genes or other haemoglobinopathies were searched for. Diagnosis was performed by haematologists, whereby the family history was evaluated, together with the overall clinical condition, blood count and blood smear, iron and haemolysis parameters, mutations of hereditary haemochromatosis, and haemoglobin electrophoresis testing. In the last years the haemoglobin division also examined by high performance liquid chromatography (HPLC).
Results: A clinical suspicion of the heterozygous form of beta-thalassaemia or other haemoglobinopathies was documented in 554 patients. Of them 32 (5.8%) were foreigners. 213 (38.45%) patients were genetically examined. In 190 (33.93%) of them heterozygote beta-thalassaemia was confirmed. The most frequent mutations were IVS 1.110 (33.15%), IVS 2.1 (33.15%), and IVS 1.6 (14.7%). Evidence of haemoglobin S (heterozygote sickle cell anaemia) was also notable in two non-relative children, whose fathers were of African origin, and one patient from Ghana. One female patient was followed up for haemoglobin Santa Ana (non-stabile haemoglobin previously diagnosed as mutation de novo). In our group, we took care of pregnant patients with haemoglobinopathies.
Conclusions: The study showed that there is a higher number of heterozygotes for beta-thalassaemia and rarely haemoglobinopathies in Slovakia. Over the past years, we have recorded an increase number of foreigners coming to our country. It is necessary to continue in search of pathological gene carriers to avoid serious forms of haemoglobinopathies.
Klíčová slova: haemoglobinopathies, thalassaemias, sickle cell anaemia, epidemiological study, Slovakia, ENERCA
Vloženo: 21. červen 2015; Revidováno: 20. prosinec 2016; Přijato: 20. prosinec 2016; Zveřejněno: 1. březen 2017 Zobrazit citaci
Reference
- Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surrallés J, Castella M, et al. Epidemiology of rare anaemias in Europe. Adv Exp Med Biol. 2010;686:375-96.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Aguilar Martinez P, Angastiniotis M, Eleftheriou A, Gulbis B, Mañú Pereira M del Mar, Petrova-Benedict R, et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis. 2014 Jul 1;9:97. doi: 10.1186/1750-1172-9-97.
Přejít k původnímu zdroji...
Přejít na PubMed...
- de Montalembert M, FersterA, Colombatti R, Rees DC, Gulbis B; European Network for Rare and CongenitalAnaemias. ENERCAclinical recommendations for disease management and prevention of complications of sickle cell disease in children. Am J Hematol. 2011 Jan;86(1):72-5.
Přejít k původnímu zdroji...
Přejít na PubMed...
- European Union Committee of Experts on Rare Disease (EUCERD). EUCERD Core recommendations on rare disease patient registration and data collection [Internet]. EUCERD; 2013 [cited 2016 Dec 20]. Available from: http://www.eucerd.eu/wp-content/uploads/2013/06/EUCERD_Recommendations_RDRegistryDataCollection_adopted.pdf.
- Vives Corrons JL, Maňu Pereira M, Olaya L. New e-Health services for the European network for rare and congenital anaemias (e-ENERCA). Orphanet J Rare Dis. 2014 Jul 1;9(1):861. doi: 10.1186/1750-1172-9-S1P9.
Přejít k původnímu zdroji...
- Indrák K, Divoký V, Brabec V, Chrobák L, Mociková K, Sakalová A, et al. Dominant beta-thalassaemie alleles in the Czech and Slovak population (beta-thalassaemie mutations in the codons 112 (TA) and 121 (GT) and unstabile hemoglobin varriants Hradec Králové or alpha,2,beta,2,115 (G17Ala-Asp). Vnitr Lek. 1994;40(4):223-30. (In Czech.)
Přejít na PubMed...
- Fábryová V, Babusík P, Laluhová-Striezencová Z, Drakulová M, Oslancová M, Macichová M, SakalováA. Nineteen years study of beta-thalassaemia in Slovakia. Cent Eur J Public Health. 2012 Dec;20(4):239-43.
Přejít k původnímu zdroji...
- Ghosh K, Colah R, Manglani M, Choudhry VP, Verma I, Madan N, et al. Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet. 2014 Apr;20(2):101-19.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Thalassaemia Internation Federation. The future od hemoglobin disorders and rare anaemias in Europe: observations, key findings and recommendations. Consensus document Thalassemia international federation (TIF). 4th Pan-European conference 7-9 November 2014,Athens, Greece. Nicosia: Thalassaemia Internation Federation; 2014.
- Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Mañú Pereira M, Corrons JL. Neonatal haemoglobinopathy screening in Spain. J Clin Pathol. 2009 Jan;62(1):22-5. doi: 10.1136/jcp.2008.058834.
Přejít k původnímu zdroji...
Přejít na PubMed...
- ENERCA, TIF, IOM. Haemoglobinopathies on the Move: Is Europe ready? [Internet]. ENERCA; 2013 [cited 2016 Dec 20]. Available from: https://www.enerca.org/media/upload/arxius/Training/Novartis_OncologyReport_2013.pdf.
- Dyson SM, Culley L, Gill C, Hubbard S, Kennefick A, Morris P, et al. Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires. Ethn Health. 2006 May;11(2):169-89.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Colombatti R, Dalla Pozza LV, Mazzucato M, Sainati L, Pierobon M, Facchin P. Hospitalization of children with sickle cell disease in a region with increasing immigration rates. Haematologica. 2008 Mar;93(3):463-4.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int. 2011 Aug;108(31-32):532-40.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Ryan K, Bain BJ, Worthington D, James J, Plews D, Mason A, et al.; British Committee for Standards in Haematology. Significant haemoglobinopathies: guidelines for screening and diagnosis. Br J Haematol. 2010 Apr;149(1):35-49.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Loukopoulos D. Haemoglobinopathies in Greece: prevention programme over the past 35 years. Indian J Med Res. 2011 Oct;134:572-6.
- CaoA. Carrier screening and genetic counselling in beta-thalassemia. Int J Hematol. 2002 Aug;76 Suppl 2:105-13.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Fábryová V, Božek P, Kollárová A. Haemoglobin diseases. Bratislava: A-medi management; 2015. (In Slovak.)
- Divoka M, Partschova M, Kucerova J, Mojzikova R, Cermak J, Pospisilova D, et al. Molecular Characterization of β-Thalassemia in the Czech and Slovak Populations: Mediterranean, Asian and Unique Mutations. Hemoglobin. 2016 Jun;40(3):156-62.
Přejít k původnímu zdroji...
Přejít na PubMed...
- TaherA, Vichinsky E, Musallam K, Cappelini MD, Viprakasit V, Weatherall DJ. Guidelines for the management of non-transfusion dependent thalassaemia (NTDT). Nicosia, Cyprus:Thalasaemia international federation; 2013.
- Sakalova A. Current problems of diagnosis and treatment of congenital haemolytic anaemia. Slov Lek. 1992;2/16(8-9):39-45. (In Slovak.)
- Wood B, Higgs D. Molecular basis of thalassaemia syndromes. In: Beaumont C, Beris P, Beuzard Y, Brugnara C, editors. Disorders of erythropoesis, erythrocytes and iron metabolism. Paris: ESH; 2009. p. 251-63.
- Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010 Jun 3;115(22):4331-6.
Přejít k původnímu zdroji...
Přejít na PubMed...
- Piel F. Global epidemiology of haemoglobinopathies: new management challenges. European haematology association learning centre. 2015 Jun 12:103588.
- Vives Corrons JL, Maňu Pereira M. ENERCA: The European network for patients with rare anaemias. J Rare Dis Diagn Ther. 2015; 1(1):1-9.
Přejít k původnímu zdroji...